FindTrial
Sign In

Clinical outcomes following Biodegradable polymer sirolimus-eluting stent implantation for the coronary artery disease patients with diabetes mellitus

Clinical outcomes following Biodegradable polymer sirolimus-eluting stent implantation for the coronary artery disease patients with diabetes mellitus or pre-diabetes

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CRIS
Registry ID
KCT0005008
Enrollment
795
Registered
2020-05-12
Start date
2019-03-18
Completion date
Unknown
Last updated
2020-05-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Wonkwang University Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients treated with Orsiro stent Patients had a medical history of diabetes or had more than 5.7 of HbA1c on blood tests.

Exclusion criteria

Exclusion criteria: Patients treated with other stents within 3 months of index procedure Patients who had less than 1 year of life expectancy Patients who were pregnant or had the possibility of pregnancy

Design outcomes

Secondary

MeasureTime frame
Major adverse cardiac event—

Primary

MeasureTime frame
Target vessel failure—

Countries

Korea, Republic of

Contacts

Public ContactKyeong Ho Yun

Wonkwang University Hospital

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026